Gene expression in human osteoblastic cells from normal and heterotopic ossification

Experimental and Molecular Pathology

Volumn 76, Issue 1, 2004, Pages 37-43

  Chauveau, Christophe ^a   Devedjian, Jean Christophe ^a   Blary, Marie Claude ^a   Delecourt, Christophe ^b   Hardouin, Pierre ^a   Jeanfils, Joseph ^a   Broux, Odile ^a  

^a Physiopathologie des Maladies Osseuses Inflammatoires   (France)

^b Groupe Hopale   (France)

Author keywords

Head injury; Heterotopic ossification; Osteocalcin mRNA; Quantitative RT PCR

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN;

ADULT; ARTICLE; BONE BIOPSY; BONE RESECTION; CELL FRACTIONATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEAD INJURY; HETEROTOPIC OSSIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; OSTEOBLAST; PATHOGENESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0346040261     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.10.001     Document Type: Article

References (23)

1. Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem. Biophys. Res. Commun. 265:1999;134-139.
2. Bidner S.M., Rubins I.M., Desjardins J.V., Zukor D.J., Goltzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J. Bone Jt. Surg., Am. 72(8):1990;1144-1149.
3. Bord S., Horner A., Beeton C.A., Hembry R.M., Compston J.E. Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone. 24(3):1999;229-235.
4. Brook C.G., Valman H.B. Osteoma cutis and Albright's hereditary osteodystrophy. Br. J. Dermatol. 85:1971;471-475.
5. Cohen R.B., Hahn G.V., Tabas J.A., Peeper J., Levitz C.L., Sando A., Sando N., Zasloff M., Kaplan F.S. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients. J. Bone Jt. Surg. 75A:1993;215-219.
6. Ducy P., Zhang R., Geoffroy V., Ridall A., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89:1997;747-754.
7. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods. 25:2001;386-401.
8. Haynesworth S.E., Baber M.A., Caplan A.L. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 13:1992;69-80.
9. Ippolito E., Formisano R., Caterini R., Farsetti P., Penta F. Operative treatment of heterotopic hip ossification in patients with coma after brain injury. Clin. Orthop. Relat. Res. 365:1999;130-138.
10. Kaplan F.S., Craver R., MacEwen G.D., Gannon F.H., Finkel G., Hahn G., Tabas J., Gardner R.J., Zasloff M.A. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J. Bone Jt. Surg. 76A:1994;425-436.
11. Kaysinger K.K., Ramp W.K., Lang G.J., Gruber H.E. Comparison of human osteoblasts and osteogenic cells from heterotopic bone. Clin. Orthop. Relat. Res. 342:1997;181-191.
12. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 79:1997;755-764.
13. Kurer M.H.J., Khoker M.A., Dandona P. Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification. Paraplegia. 30:1992;165-168.
14. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
15. Pittenger D.E. Heterotopic ossification. Orthop. Rev. 20:1991;33-39.
16. Puzas J.E., Brand J.S., Evarts C.M. The stimulus for bone formation. Brand J.S. The hip. 1987;25-38 Mosby CV, St Louis.
17. Renfree K.J., Banovac K., Hornicek F.J., Lebwohl N.H., Villanueva P.A., Nedd K.J. Evaluation of serum osteoblast mitogenic activity in spinal cord and head injury patients with acute heterotopic ossification. Spine. 19(7):1994;740-746.
18. Sawyer J.R., Myers M.A., Rosier R.N., Puzas J.E. Heterotopic ossification: clinical and cellular aspects. Calcif. Tissue Int. 49:1991;208-215.
19. Sell S., Gaissmaier C., Fritz J., Herr G., Esenwein S., Kusswetter W., Volkmann R., Wittkowski K.M., Rodemann H.P. Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone in vitro. Calcif. Tissue Int. 62:1998;51-59.
20. Shehab D., Elgazzar A.H., Collier D. Heterotopic ossification. J. Nucl. Med. 43(3):2002;346-353.
21. Stein G.S., Lian J.B., Gerstenfeld L.G., Shalhoub V., Aronow M., Owen T., Markose E. The onset of progression of osteoblast differentiation is functionally related to cellular proliferation. Connect. Tissue Res. 20:1989;3-13.
22. Wilkinson J.M., Stockley I., Hamer A.J., Barrington N.A., Eastell R. Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty. J. Orthop. Res. 21:2003;529-534.
23. Zhou H., Choong P., Mc Carthy R., Chou S.T., Martin T.J., Ng K.W. In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J. Bone Miner. Res. 9:1994;1489-1499.